Cessation Therapeutics
PrivateLast Round
Grant
Oct 18, 2023
Total Funding Raised
$21.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cessation Therapeutics is a biotechnology company that develops novel immunobiologics and monoclonal antibody therapies to prevent and treat fentanyl-related overdoses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cessation Therapeutics Comparables
Compare Cessation Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CounterX Therapeutics | 89% | |
| InterveXion | 88% | |
| ARMR Sciences Inc. | 84% | |
Cessation Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 18, 2023 | ||||
| Grant | Sep 1, 2020 |
Key People
Founding team and executive leadership
Cessation Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JDH Investment Management | Initial Funding |
| Johnson & Johnson Innovation - JLABS | Initial Funding |
| Altamont Pharmaceutical Holdings | Initial Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 657% MoM, reaching 1.4K.
- Oct 18, 2023
$15M grant received from McLean Hospital.
Cessation Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cessation Therapeutics's valuation, stock price, and market status.